Product Launches
The United States Food and Drug Administration (USFDA) has approved Simponi (Golimumab) injections for the treatment of severe forms of ulcerative colitis in adults. ..
20-May-2013
The United States Food and Drug Administration (USFDA) has approved Nymalize, a first oral formulation of Nimodipine that can potentially lower fatal medication errors. Nymalize is indicated for the treatment of subarachnoid haemorrhage...
15-May-2013
Breo Ellipta (Fluticasone Furoate and Vilanterol Inhalation Powder), a new combined formulation developed by GlaxoSmithKline in collaboration with Theravance has been approved in United States Food and Drug Administration (USFDA). ..
13-May-2013
The United States Food and Drug Administration (USFDA) has approved Liptruzet (Atorvastatin and Ezetimibe) for the treatment of patients with high LDL levels with primary or mixed hyperlipidemia. The drug should be prescribed if other medical management a..
07-May-2013
The United States Food and Drug Administration (USFDA) has approved Plan B One-Step as OTC prescription for girls aged 15 years and over. The drug has been developed by Teva Women?s Health Inc. The plan B contains Levonorgestrel...
06-May-2013
The United States Food and Drug Administration has approved Procysbi (Cysteamine bitartrate) for the treatment of nephropathic cystinosis in adults and children. The drug has been approved with orphan drug status as it is approved ..
29-Apr-2013
The United States Food and Drug Administration (USFDA) has approved Amitiza (Lubiprostone) being manufactured by Sucampo Pharmaceuticals and Takeda Pharmaceuticals. Amitiza is a supplemental new drug that should be taken twice daily (24 mcg) for the manag..
23-Apr-2013
The United States Food and Drug Administration (USFDA) has approved the FibroScan(R), a medical device developed by Echosens. The device has been approved based on 510(K) clearance. Around 1800 devices are being used in the US for clinical and research pu..
22-Apr-2013
The United States Food and Drug Administration (USFDA) has approved the treatment of Sitavig (Acylovir) for the treatment of recurring Herpes Labialis. Sitavig is being marketed by BioAlliance Pharma SA. High concentration ..
16-Apr-2013
The United States Food and Drug Administration (USFDA) has re-approved Diclegis (Doxylamine Succinate and Pyridoxine Hydrochloride) that was banned thirty years ago. The drug has been indicated for the treatment of gestational nausea and vomiting. Diclegi..
Showing 1 - 10 of total 90 records
Home | Video | News | Drug Index | New Products | Journals | Events | Pharmaceutical Manufacturers | Equipment Manufacturers | My DU
